Sort by
Refine Your Search
-
to separate and process the isotopes. This dependency creates a vulnerable and unsustainable supply chain, slowing innovation in nuclear medicine and limiting patient access to new therapies. The Terbium
-
targeted therapy. However, their development is constrained by limited access to essential enriched starting materials and the complex technologies required to separate and process the isotopes
-
how a tumour responds to therapy across biological scales, are both betting that structure beats brute scale. In this postdoc you will lead research on physics-informed (and physics-grounded) world
-
mechanisms of T-cell recognition. These discoveries will support the development of next-generation vaccine-based therapies, ultimately contributing to improved outcomes for patients with cancer. Finally, you